During the evolution of SARS-CoV-2 in humans, a D614G substitution in the spike
glycoprotein (S) has emerged; virus containing this substitution has become the predominant …

Angiotensin-converting enzyme 2 (ACE2) is a receptor for SARS-CoV, the novel coronavirus
that causes severe acute respiratory syndrome [Li, W. Moore, MJ, Vasilieva, N., Sui, J., …

Pandemic influenza A viruses that emerge from animal reservoirs are inevitable. Therefore,
rapid genomic analysis and creation of vaccines are vital. We developed a multisegment …

The global emergence of many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variants jeopardizes the protective antiviral immunity induced after infection or …

Human coronavirus HCoV-229E uses human aminopeptidase N (hAPN) as its receptor (CL
Yeager et al., Nature 357:420-422, 1992). To identify the receptor-binding domain of the …

During the 2009 H1N1 influenza pandemic, vaccines for the virus became available in large
quantities only after human infections peaked. To accelerate vaccine availability for future …

Influenza A virus is characterized by high genetic diversity 1 , 2 , 3 . However, most of what
is known about influenza evolution has come from consensus sequences sampled at the …

10.7554/eLife.05055.001 A complex interplay of viral, host, and ecological factors shapes
the spatio-temporal incidence and evolution of human influenza viruses. Although …

Background Increased illness due to antigenically drifted A(H3N2) clade 3C.3a influenza
viruses prompted concerns about vaccine effectiveness (VE) and vaccine strain selection. We …

Influenza virus defective interfering (DI) particles are naturally occurring noninfectious
virions typically generated during in vitro serial passages in cell culture of the virus at a high …